Published in J Clin Microbiol on January 01, 1988
The resurgence of tuberculosis: is your laboratory ready? J Clin Microbiol (1993) 11.70
Identification of mycobacteria by high-performance liquid chromatography. J Clin Microbiol (1991) 7.27
Current practices in mycobacteriology: results of a survey of state public health laboratories. J Clin Microbiol (1993) 5.99
Differentiation of slowly growing Mycobacterium species, including Mycobacterium tuberculosis, by gene amplification and restriction fragment length polymorphism analysis. J Clin Microbiol (1992) 5.20
Agents of newly recognized or infrequently encountered mycobacterial diseases. Clin Microbiol Rev (1992) 5.11
Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by using high-performance liquid chromatography of mycolic acids. J Clin Microbiol (1992) 3.36
High-performance liquid chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium smegmatis. J Clin Microbiol (1990) 3.27
Use of Gen-Probe AccuProbes to identify Mycobacterium avium complex, Mycobacterium tuberculosis complex, Mycobacterium kansasii, and Mycobacterium gordonae directly from BACTEC TB broth cultures. J Clin Microbiol (1994) 3.11
Identification of Mycobacterium avium complex strains and some similar species by high-performance liquid chromatography. J Clin Microbiol (1992) 3.03
Genotypic identification of pathogenic Mycobacterium species by using a nonradioactive oligonucleotide probe. J Clin Microbiol (1991) 2.90
A rapid method for screening antimicrobial agents for activities against a strain of Mycobacterium tuberculosis expressing firefly luciferase. Antimicrob Agents Chemother (1993) 2.39
Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin Microbiol Rev (2001) 2.36
Routine application of high-performance liquid chromatography for identification of mycobacteria. J Clin Microbiol (1993) 1.92
Tuberculosis in the AIDS era. Clin Microbiol Rev (1995) 1.85
Rapid identification of mycolic acid patterns of mycobacteria by high-performance liquid chromatography using pattern recognition software and a Mycobacterium library. J Clin Microbiol (1994) 1.80
High-performance liquid chromatography of corynomycolic acids as a tool in identification of Corynebacterium species and related organisms. J Clin Microbiol (1992) 1.77
Identification of Mycobacterium tuberculosis and M. avium complex directly from smear-positive sputum specimens and BACTEC 12B cultures by high-performance liquid chromatography with fluorescence detection and computer-driven pattern recognition models. J Clin Microbiol (1995) 1.56
Direct detection of Mycobacterium tuberculosis complex in nonrespiratory specimens by Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test. J Clin Microbiol (1997) 1.52
Identification of Mycobacterium gordonae from culture by the Gen-Probe Rapid Diagnostic System: evaluation of 218 isolates and potential sources of false-negative results. J Clin Microbiol (1991) 1.50
Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States. J Clin Microbiol (2001) 1.46
High-performance liquid chromatography patterns of Mycobacterium gordonae mycolic acids. J Clin Microbiol (1992) 1.44
Routine use of PCR-reverse cross-blot hybridization assay for rapid identification of Mycobacterium species growing in liquid media. J Clin Microbiol (1998) 1.43
Comparative evaluation of PCR and commercial DNA probes for detection and identification to species level of Mycobacterium avium and Mycobacterium intracellulare. J Clin Microbiol (1996) 1.38
Molecular characterization of Mycobacterium avium complex isolates giving discordant results in AccuProbe tests by PCR-restriction enzyme analysis, 16S rRNA gene sequencing, and DT1-DT6 PCR. J Clin Microbiol (1997) 1.35
Evaluation of the new GenoType Mycobacterium assay for identification of mycobacterial species. J Clin Microbiol (2006) 1.19
Q-beta replicase-amplified assay for detection of Mycobacterium tuberculosis directly from clinical specimens. J Clin Microbiol (1995) 1.12
Differentiation of mycobacteria on the basis of chemotype profiles by using matrix solid-phase dispersion and thin-layer chromatography. J Clin Microbiol (1993) 1.08
Two cases of Mycobacterium haemophilum infection in Canada. J Clin Microbiol (1990) 1.07
Determination of drug susceptibility of Mycobacterium tuberculosis through mycolic acid analysis. J Clin Microbiol (1997) 1.06
Direct identification of Mycobacterium species in BACTEC 7H12B medium by high-performance liquid chromatography. J Clin Microbiol (1994) 1.02
Detection and identification of mycobacteria in formalin-fixed, paraffin-embedded tissues by nested PCR and restriction enzyme analysis. J Clin Microbiol (1996) 0.96
Evaluation of a fluorescence in situ hybridization assay for differentiation between tuberculous and nontuberculous Mycobacterium species in smears of Lowenstein-Jensen and Mycobacteria Growth Indicator Tube cultures using peptide nucleic acid probes. J Clin Microbiol (2001) 0.94
Evaluation of TBc identification immunochromatographic assay for rapid identification of Mycobacterium tuberculosis complex in samples from broth cultures. J Clin Microbiol (2011) 0.91
Characterization of multiple-substrate utilization by anthracene-degrading Mycobacterium frederiksbergense LB501T. Appl Environ Microbiol (2003) 0.91
A unique Mycobacterium species isolated from an epizootic of striped bass (Morone saxatilis). Emerg Infect Dis (2001) 0.88
Multiplex PCR provides a low-cost alternative to DNA probe methods for rapid identification of Mycobacterium avium and Mycobacterium intracellulare. J Clin Microbiol (1996) 0.82
Serum levels of soluble interleukin-2 receptor in pulmonary tuberculosis. Korean J Intern Med (1990) 0.75
Differential identification of mycobacteria. VII. Key features for identification of clinically significant mycobacteria. Am Rev Respir Dis (1973) 6.76
Phenacyl esters of fatty acids via crown ether catalysts for enhanced ultraviolet detection in liquid chromatography. Anal Chem (1975) 3.74
Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis (1982) 3.38
Mycolic acid patterns of some species of Mycobacterium. Arch Microbiol (1984) 3.02
Mycobacterium simiae and Mycobacterium avium-M. intracellulare mixed infection in acquired immune deficiency syndrome. J Clin Microbiol (1987) 3.01
Lipid composition in the classification and identification of acid-fast bacteria. Soc Appl Bacteriol Symp Ser (1980) 2.82
Differentiation of Mycobacterium, Nocardia, and related taxa by thin-layer chromatographic analysis of whole-organism methanolysates. J Gen Microbiol (1975) 2.70
High-performance liquid chromatography of mycolic acids as a tool in the identification of Corynebacterium, Nocardia, Rhodococcus, and Mycobacterium species. J Clin Microbiol (1986) 2.51
The major mycolic acids of Mycobacterium smegmatis. Characterization of their homologous series. J Biol Chem (1979) 1.92
Characterization of the purified components of a new homologous series of alpha-mycolic acids from Mycobacterium tuberculosis H37Ra. J Biol Chem (1978) 1.80
Mycolic acid patterns of representative strains of Mycobacterium fortuitum, 'Myobacterium peregrinum' and Mycobacterium smegmatis. J Gen Microbiol (1984) 1.67
Mycolic acids. A reinvestigation. J Biol Chem (1978) 1.67
Studies on the mycolic acids from the walls of Mycobacterium microti. J Gen Microbiol (1982) 1.49
Structures of the two homologous series of dialkene mycolic acids from Mycobacterium smegmatis. J Biol Chem (1982) 1.47
Structures of the homologous series of monoalkene mycolic acids from Mycobacterium smegmatis. J Biol Chem (1979) 1.30
An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med (1992) 18.11
The emergence of drug-resistant tuberculosis in New York City. N Engl J Med (1993) 12.71
Identification of mycobacteria by high-performance liquid chromatography. J Clin Microbiol (1991) 7.27
In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob Agents Chemother (1996) 5.08
Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis (1981) 4.77
Separation of Mycobacterium bovis BCG from Mycobacterium tuberculosis and Mycobacterium bovis by using high-performance liquid chromatography of mycolic acids. J Clin Microbiol (1992) 3.36
High-performance liquid chromatography patterns of mycolic acids as criteria for identification of Mycobacterium chelonae, Mycobacterium fortuitum, and Mycobacterium smegmatis. J Clin Microbiol (1990) 3.27
Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis (1993) 3.16
Identification of Mycobacterium avium complex strains and some similar species by high-performance liquid chromatography. J Clin Microbiol (1992) 3.03
Mycobacterium celatum sp. nov. Int J Syst Bacteriol (1993) 2.97
Inhibition of synthesis of arabinogalactan by ethambutol in Mycobacterium smegmatis. Antimicrob Agents Chemother (1989) 2.68
Isolation and characterization of a unique group of slowly growing mycobacteria: description of Mycobacterium lentiflavum sp. nov. J Clin Microbiol (1996) 2.66
High-performance liquid chromatography of mycolic acids as a tool in the identification of Corynebacterium, Nocardia, Rhodococcus, and Mycobacterium species. J Clin Microbiol (1986) 2.51
Multidrug-resistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis (1994) 2.45
Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol (1982) 2.44
Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism. J Clin Microbiol (1993) 2.40
Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity. Antimicrob Agents Chemother (1983) 2.25
Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis. Antimicrob Agents Chemother (1979) 2.24
High-performance liquid chromatography analysis of mycolic acids as an aid in laboratory identification of Rhodococcus and Nocardia species. J Clin Microbiol (1987) 1.95
In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin. Am Rev Respir Dis (1982) 1.92
Differential identification of mycobacteria. I. Tests on catalase activity. Am Rev Respir Dis (1966) 1.89
Laboratory aspects of "Mycobacterium genavense," a proposed species isolated from AIDS patients. J Clin Microbiol (1992) 1.82
Rapid identification of mycolic acid patterns of mycobacteria by high-performance liquid chromatography using pattern recognition software and a Mycobacterium library. J Clin Microbiol (1994) 1.80
Effect of ethambutol on the viable cell count in Mycobacterium smegmatis. Antimicrob Agents Chemother (1977) 1.72
Chronic tenosynovitis of the hand due to Mycobacterium nonchromogenicum: use of high-performance liquid chromatography for identification of isolates. Rev Infect Dis (1992) 1.70
Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. Am Rev Respir Dis (1985) 1.56
Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. J Med Chem (1996) 1.54
Effects of ethambutol on phospholipid metabolism in Mycobacterium smegmatis. Antimicrob Agents Chemother (1981) 1.47
Effects of ethambutol on accumulation and secretion of trehalose mycolates and free mycolic acid in Mycobacterium smegmatis. Antimicrob Agents Chemother (1981) 1.37
Differential identification of Mycobacteria. V. The tellurite reduction test. Am Rev Respir Dis (1969) 1.29
A continuing survey of tuberculosis primary drug resistance in the United States: March 1975 to November 1977. A United States Public Health Service cooperative study. Am Rev Respir Dis (1978) 1.25
Drug-resistant tuberculosis. Am Rev Respir Dis (1991) 1.20
Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med (1994) 1.20
Bacteriologic investigations of unusual mycobacteria isolated from immunocompromised patients. Diagn Microbiol Infect Dis (1993) 1.04
Susceptibility of mycobacteria to rifampin. Antimicrob Agents Chemother (1972) 1.04
Preparation of a stable mycobacterial tween hydrolysis test substrate. Appl Microbiol (1973) 1.01
Reagent-impregnated paper strip for detection of metabolic products of isoniazid in urine. Am Rev Respir Dis (1972) 0.98
Modified method for testing the quality of albumin-containing enrichments used in growth media for mycobacteria. J Clin Microbiol (1990) 0.95
Asparatic acid as a precursor for niacin synthesis by tubercle bacilli grown on 7H-10 agar medium. Am J Clin Pathol (1968) 0.94
Effect of low temperature on growth, viability, and synthesis of mycolic acids of Mycobacterium tuberculosis strain H37Ra. Am Rev Respir Dis (1978) 0.90
Characterization of autolysins from Mycobacterium smegmatis. J Bacteriol (1977) 0.90
HIV infection and primary resistance to antituberculosis drugs in Abidjan, Côte d'Ivoire. AIDS (1992) 0.89
Reagent-impregnated paper strips for detection of niacin. Am J Clin Pathol (1968) 0.84
Differentiation of Mycobacterium genavense and Mycobacterium simiae by automated mycolic acid analysis with high-performance liquid chromatography. J Clin Microbiol (1996) 0.84
Synthesis of trehalose dimycolate (cord factor) by a cell-free system of Mycobacterium smegmatis. Biochem Biophys Res Commun (1982) 0.81
Reagent-impregnated paper strips for detection of niacin. Tech Bull Regist Med Technol (1968) 0.81
Differential identification of mycobacteria. IV. The nitrite inhibition test. Am Rev Respir Dis (1968) 0.75